4//SEC Filing
Wooldridge James 4
Accession 0001140361-17-033209
CIK 0001636282other
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 6:04 PM ET
Size
8.1 KB
Accession
0001140361-17-033209
Insider Transaction Report
Form 4
Wooldridge James
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2017-08-22+165,000→ 165,000 totalExercise: $3.10Exp: 2027-08-21→ Common Stock (165,000 underlying) - Award
Employee Stock Option (right to buy)
2017-08-22+10,000→ 10,000 totalExercise: $3.10Exp: 2027-08-21→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The stock option vests and becomes exercisable as to 1/4th of the shares subject to the option on July 10, 2018, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
- [F2]The stock option vests and becomes exercisable as to 50% of the shares subject to the option on August 22, 2018, an additional 30% of the shares subject to the option on August 22, 2019, and the remaining 20% of the shares subject to the option on August 22, 2020, subject to the continuing employment of the Reporting Person on each vesting date.
Documents
Issuer
Aeglea BioTherapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001710641
Filing Metadata
- Form type
- 4
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 6:04 PM ET
- Size
- 8.1 KB